Citadel Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.08M | Buy |
4,113,588
+2,380,785
| +137% | +$4.09M | ﹤0.01% | 1618 |
|
|
2025
Q1 | $5.77M | Buy |
1,732,803
+639,199
| +58% | +$2.13M | ﹤0.01% | 1641 |
|
|
2024
Q4 | $8.09M | Buy |
1,093,604
+69,768
| +7% | +$516K | ﹤0.01% | 1452 |
|
|
2024
Q3 | $9.61M | Buy |
1,023,836
+780,578
| +321% | +$7.33M | ﹤0.01% | 1291 |
|
|
2024
Q2 | $1.95M | Sell |
243,258
-867,739
| -78% | -$6.96M | ﹤0.01% | 2463 |
|
|
2024
Q1 | $16.5M | Buy |
1,110,997
+824,963
| +288% | +$12.2M | ﹤0.01% | 997 |
|
|
2023
Q4 | $2.33M | Sell |
286,034
-103,101
| -26% | -$838K | ﹤0.01% | 2277 |
|
|
2023
Q3 | $1.77M | Sell |
389,135
-945,312
| -71% | -$4.3M | ﹤0.01% | 2503 |
|
|
2023
Q2 | $9.39M | Sell |
1,334,447
-2,137,584
| -62% | -$15M | ﹤0.01% | 1254 |
|
|
2023
Q1 | $21.2M | Buy |
3,472,031
+1,177,989
| +51% | +$7.2M | ﹤0.01% | 822 |
|
|
2022
Q4 | $14.7M | Buy |
2,294,042
+1,862,210
| +431% | +$11.9M | ﹤0.01% | 1054 |
|
|
2022
Q3 | $4.14M | Sell |
431,832
-2,089,992
| -83% | -$20M | ﹤0.01% | 2033 |
|
|
2022
Q2 | $27.8M | Buy |
2,521,824
+2,386,618
| +1,765% | +$26.3M | 0.01% | 642 |
|
|
2022
Q1 | $2.25M | Sell |
135,206
-110,752
| -45% | -$1.84M | ﹤0.01% | 2883 |
|
|
2021
Q4 | $4.7M | Sell |
245,958
-1,107,605
| -82% | -$21.1M | ﹤0.01% | 2153 |
|
|
2021
Q3 | $33.4M | Sell |
1,353,563
-1,024,101
| -43% | -$25.3M | 0.01% | 625 |
|
|
2021
Q2 | $61.9M | Buy |
2,377,664
+1,621,945
| +215% | +$42.2M | 0.01% | 403 |
|
|
2021
Q1 | $23.9M | Sell |
755,719
-570,173
| -43% | -$18.1M | 0.01% | 829 |
|
|
2020
Q4 | $61.5M | Buy |
1,325,892
+34,494
| +3% | +$1.6M | 0.02% | 354 |
|
|
2020
Q3 | $42.5M | Sell |
1,291,398
-549,748
| -30% | -$18.1M | 0.01% | 453 |
|
|
2020
Q2 | $50.5M | Buy |
1,841,146
+1,432,331
| +350% | +$39.3M | 0.02% | 371 |
|
|
2020
Q1 | $12.2M | Buy |
408,815
+103,031
| +34% | +$3.08M | 0.01% | 879 |
|
|
2019
Q4 | $8.46M | Buy |
305,784
+220,465
| +258% | +$6.1M | ﹤0.01% | 1275 |
|
|
2019
Q3 | $1.55M | Sell |
85,319
-217,528
| -72% | -$3.96M | ﹤0.01% | 2568 |
|
|
2019
Q2 | $7.43M | Sell |
302,847
-1,636,021
| -84% | -$40.1M | ﹤0.01% | 1376 |
|
|
2019
Q1 | $18.4M | Sell |
1,938,868
-2,488,645
| -56% | -$23.7M | 0.01% | 783 |
|
|
2018
Q4 | $39.2M | Buy |
4,427,513
+1,126,352
| +34% | +$9.97M | 0.02% | 406 |
|
|
2018
Q3 | $37.1M | Buy |
3,301,161
+2,841,526
| +618% | +$32M | 0.02% | 502 |
|
|
2018
Q2 | $5.88M | Buy |
459,635
+264,160
| +135% | +$3.38M | ﹤0.01% | 1304 |
|
|
2018
Q1 | $3.3M | Buy |
195,475
+163,531
| +512% | +$2.76M | ﹤0.01% | 1572 |
|
|
2017
Q4 | $256K | Sell |
31,944
-23,380
| -42% | -$187K | ﹤0.01% | 3228 |
|
|
2017
Q3 | $429K | Buy |
+55,324
| New | +$429K | ﹤0.01% | 2777 |
|
|
2017
Q2 | – | Sell |
-53,562
| Closed | -$399K | – | 3904 |
|
|
2017
Q1 | $399K | Buy |
53,562
+12,806
| +31% | +$95.4K | ﹤0.01% | 2742 |
|
|
2016
Q4 | $283K | Sell |
40,756
-5,984
| -13% | -$41.6K | ﹤0.01% | 2849 |
|
|
2016
Q3 | $385K | Buy |
46,740
+27,086
| +138% | +$223K | ﹤0.01% | 2622 |
|
|
2016
Q2 | $159K | Buy |
19,654
+7,021
| +56% | +$56.8K | ﹤0.01% | 2876 |
|
|
2016
Q1 | $64K | Sell |
12,633
-21,678
| -63% | -$110K | ﹤0.01% | 2967 |
|
|
2015
Q4 | $265K | Buy |
+34,311
| New | +$265K | ﹤0.01% | 2792 |
|
|
2015
Q3 | – | Sell |
-63,781
| Closed | -$585K | – | 4147 |
|
|
2015
Q2 | $585K | Buy |
+63,781
| New | +$585K | ﹤0.01% | 2456 |
|